SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1-, or EGFR-altered Non–small Cell Lung …
H Kano, E Ichihara, H Watanabe, K Nishii, C Ando… - Molecular cancer …, 2021 - AACR
… We hypothesized a role for another RTK in sustaining or reactivating the ERK pathway in
the residual tumor cells after TKI exposure. However, a search using a phosphorylated RTK …
the residual tumor cells after TKI exposure. However, a search using a phosphorylated RTK …
Abstract LB-119: SHP2 drives adaptive resistance to ERK signaling inhibition in molecularly defined subsets of ERK-dependent tumors
… commonly due to activating mutations of pathway components such as in RAS and …
reactivation of ERK is driven by ERBB or MET receptors and is therefore mediated by SHP2 ("SHP2-…
reactivation of ERK is driven by ERBB or MET receptors and is therefore mediated by SHP2 ("SHP2-…
[HTML][HTML] SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition
X Lai, SKL Lui, HY Lam, Y Adachi, WJ Sim… - NPJ Precision …, 2023 - nature.com
… inhibitors through reactivation of MAPK signalling. As a result of the oncogenic activity of
SHP2, several SHP2 inhibitors … if SHP2 inhibition could similarly alter BMP pathway activation. …
SHP2, several SHP2 inhibitors … if SHP2 inhibition could similarly alter BMP pathway activation. …
[HTML][HTML] Gamma tocotrienol targets tyrosine phosphatase SHP2 in mammospheres resulting in cell death through RAS/ERK pathway
… To further prove that SHP2 biological function was inhibited by γ-T3 … pathway Ras is a
direct downstream component of SHP2, hence we assumed that the down-regulation of SHP2 …
direct downstream component of SHP2, hence we assumed that the down-regulation of SHP2 …
SHP2 Inhibition Suppresses RAS-ERK Signaling, the Development of JAK2 Inhibitor Persistence, and MPN Development in Pre-Clinical Models of Myeloproliferative …
G Pandey, N Horvat, NE Amin, G Zhang, L Mazzacurati… - Blood, 2022 - ashpublications.org
… , this was suppressed when SHP2 activity was inhibited. Since SHP2 signals to activate the
RAS-ERK pathway and inhibition of SHP2 suppressed ERK reactivation in ruxolitinib treated …
RAS-ERK pathway and inhibition of SHP2 suppressed ERK reactivation in ruxolitinib treated …
A combination vertical inhibition approach with inhibitors of SHP2 and ERK provides improved activity in KRAS-mutant pancreatic and colorectal cancer models
C Hindley, A Biondo, J Brothwood, KH Dao… - European Journal of …, 2022 - ejcancer.com
… Vertical pathway combination strategies are … pathway reactivation. Src homology region
2-containing protein tyrosine phosphatase 2 (SHP2) is a key regulator of the MAPK pathway …
2-containing protein tyrosine phosphatase 2 (SHP2) is a key regulator of the MAPK pathway …
[HTML][HTML] SHP2 inhibition improves celastrol-induced growth suppression of colorectal cancer
L Zhang, X Hu, Q Meng, Y Li, H Shen, Y Fu… - Frontiers in …, 2022 - frontiersin.org
… The SHP2 inhibitor blocked the reactivation of receptor tyrosine kinase-derived AKT/ERK …
would greatly block this feedback pathway so that presented synergic anti-CRC effect with low-…
would greatly block this feedback pathway so that presented synergic anti-CRC effect with low-…
Resveratrol inhibits collagen-induced platelet stimulation through suppressing NADPH oxidase and oxidative inactivation of SH2 domain-containing protein tyrosine …
JY Jang, JH Min, SB Wang, YH Chae, JY Baek… - Free radical biology and …, 2015 - Elsevier
… -dependent signaling pathways in collagen-stimulated platelets. … After reactivating the
reversibly oxidized SHP-2 by DTT … the inhibition of NOX, ROS-dependent inactivation of SHP-2 …
reversibly oxidized SHP-2 by DTT … the inhibition of NOX, ROS-dependent inactivation of SHP-2 …
HER-2/neu raises SHP-2, stops IFN-γ anti-proliferation in bladder cancer
WP Su, IH Tu, SW Hu, HH Yeh, DB Shieh… - Biochemical and …, 2007 - Elsevier
… SHP-2 in MBT2 cells and reactivated Stat1 in TCC-N5 and TCC-N10 cells. AG825 inhibited
the HER-2 pathway … cells with AG825 downregulated SHP-2 and reactivated Stat1. Similar …
the HER-2 pathway … cells with AG825 downregulated SHP-2 and reactivated Stat1. Similar …
Redox regulation of a gain-of-function mutation (N308D) in SHP2 noonan syndrome
… the SHP2 N308D catalytic domain can be reactivated by … of signaling pathways, especially
the RAS/ERK signaling pathway that … Inhibition and reactivation of the steady-state activity of …
the RAS/ERK signaling pathway that … Inhibition and reactivation of the steady-state activity of …